COPD Management: Evidence Report on Ensifentrine 🌬️ Breathe easier with new COPD treatment insights! Discover how #Ensifentrine could improve life for millions. 🏥💡 Read our latest article on #COPDmanagement and learn about the potential of this innovative therapy as well as its cost-effectiveness. #RespiratoryHealth #PatientCare #HealthcareInnovation https://lnkd.in/dAqHd8x3
Syenza News’ Post
More Relevant Posts
-
If you have committed your life to improving the Quality of Life in COPD patients, this is a recent paper about the interaction between QoL and Meaning in Life (MIL) in COPD you need to familiarize yourself with: https://lnkd.in/g6JTBnBU #COPD #QoL #MayoClinic #TheBiggerPicture
JCOPDF-2023-0476-Batzlaff.pdf
journal.copdfoundation.org
-
5 things COPD patients want their doctors to know, according to real patients and caregivers https://lnkd.in/gdzRFyq3
5 things COPD patients want their doctors to know, according to real patients and caregivers | MDLinx
mdlinx.com
-
Do you have any insights on this? A study on COPD that is focused on human factors and patient needs, with an aim to understand the challenges patients face in order to support the development of treatment. https://lnkd.in/eMWv8QRt #RespiratoryPC
The patient journey in Chronic Obstructive Pulmonary Disease (COPD): a human factors qualitative international study to understand the needs of people living with COPD - BMC Pulmonary Medicine
bmcpulmmed.biomedcentral.com
-
Prof. & Head, Department of Respiratory Medicine
https://lnkd.in/gUqtJfQf Can muscle wasting responsible for increase in grade of Dyspnoea in severe stage of COPD?
(PDF) Study the Association of Fat-free Mass Index with Disease Severity in COPD Patients by Conducting 6-minute Walk Test
researchgate.net
-
Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis https://lnkd.in/ecBuNRgd
Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
err.ersjournals.com
-
Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis https://lnkd.in/ecBuNRgd
Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
err.ersjournals.com
-
Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory conditions. It is the third leading cause of death worldwide, according to the World Health Organization. COPD is not curable, but early detection is important to slow its progression. Symptoms can go unnoticed in the early stages though, and the American Lung Association suggests there have been potentially millions of underdiagnosed cases in the past.. We’re proud to be collaborating with Koye Pharmaceuticals Pvt Ltd on a program to create a novel vocal biomarker for COPD in India, where the disease is the second biggest cause of death [https://lnkd.in/e_9RB5cE]. By leveraging our clinically validated, voice-powered respiratory health tracking platform, Koye is able to develop solutions that will enable physicians to treat their patients’ COPD symptoms more effectively. Read More 👉 https://lnkd.in/djecyEF) #vocalbiomarkers #digitalhealth
Chronic obstructive pulmonary disease (COPD)
who.int
-
Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis https://lnkd.in/ecBuNRgd
Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
err.ersjournals.com
-
Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis https://lnkd.in/ecBuNRgd
Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
err.ersjournals.com
-
Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis https://lnkd.in/e23VbscE
Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
err.ersjournals.com
Global HEOR l HTA l Specialist and Clinical Pharmacist I MSc | Medical Writer | Editor | ICH GCP | AI in Healthcare
7moGreat report. The pricing of COPD drugs are very important as its a very common disease and affordability of treatment plays a big role in compliance.